Loading...

Nonprescription COVID-19 Test Approved by FDA

March 8, 2021 by Daniel Mollenkamp
Nonprescription COVID-19 Test Approved by FDA
FILE - In this March 1, 2021, file photo, a patient receives a shot of the Moderna COVID-19 vaccine next to a guidelines sign at a CVS Pharmacy branch in Los Angeles. More than 27 million Americans fully vaccinated against the coronavirus will have to keep waiting for guidance from U.S. health officials for what they should and shouldn’t do. The Biden administration said Friday, March 5, it’s focused on getting the guidance right and accommodating emerging science. (AP Photo/Marcio Jose Sanchez, File)

WASHINGTON – The Food and Drug Administration issued an emergency authorization for a non-prescription, over the counter nostril test for coronavirus, the agency announced on Friday. 

It’s the first over the counter molecular test they have authorized for use without a prescription. 

It’s also the latest in test and collection kits authorized by the FDA to track the virus. The FDA has authorized 330 such items in its rush to expand the testing capability and access in the U.S.

The test, Cue COVID-19 Test for Home and Over The Counter, which utilizes a nasal swab, can be used by adults and children over the age of two, the agency explained in a written statement. It offers results through a mobile app in about twenty minutes, and its track record is good. The test was able to identify 96% of positive samples from people showing symptoms and 100% from people with no symptoms, the agency reported. 

It received an emergency use authorization from the FDA, a designation which is allowed to expand access during a crisis. The agency says it has prioritized emergency use applications that would increase access to testing or testing capabilities, such as this one.

Data from Johns Hopkins University indicates that positive tests in the U.S. have been declining since January, with an average of about 4.2% coming back positive as of March 5th. According to materials published by the World Health Organization in May, a positive test rate of less than 5% is one possible indicator that a country has the epidemic under control. The total new number of tests in the country has increased since last summer. 

Acting FDA Commissioner Janet Woodcock said that the approval of this test is part of the agency’s continued effort to provide flexibility to test developers in order to speed up the availability of tests.

“The FDA will continue to expand Americans’ access to testing to help us in the fight against this pandemic, which has claimed over half a million lives in the United States,” she said.

The company that makes the test, Cue Health, told the agency that it intends to produce more than 100,000 tests per day by summer.

In The News

Health

Voting

Health

January 14, 2022
by Dan McCue
White House Announces Plans to Distribute Home COVID Tests

WASHINGTON — Beginning Jan. 19, Americans will be able to order free at-home COVID-19 tests online from the federal government,... Read More

WASHINGTON — Beginning Jan. 19, Americans will be able to order free at-home COVID-19 tests online from the federal government, a senior White House official announced Friday afternoon. In the early going of the new program, individuals will be limited to four free tests per residential... Read More

Mask Rules Get Tighter in Europe in Winter's COVID-19 Wave

ROME (AP) — To mask or not to mask is a question Italy settled early in the COVID-19 outbreak with... Read More

ROME (AP) — To mask or not to mask is a question Italy settled early in the COVID-19 outbreak with a vigorous “yes." Now the onetime epicenter of the pandemic in Europe hopes even stricter mask rules will help it beat the latest infection surge. Other... Read More

January 12, 2022
by Reece Nations
House Rules Committee Rejects G.I. Bill Education Benefits for Vaccine Refusal

WASHINGTON — The House Rules Committee on Monday rejected an amendment to the Guard and Reserve G.I. Bill Parity Act... Read More

WASHINGTON — The House Rules Committee on Monday rejected an amendment to the Guard and Reserve G.I. Bill Parity Act that would guarantee Armed Services members discharged for refusing the COVID-19 vaccine are eligible for G.I. Bill education benefits. The Guard and Reserve G.I. Bill Parity... Read More

January 12, 2022
by Alexa Hornbeck
Reliability of Antigen Rapid Tests in Detecting Early Omicron Questioned

WASHINGTON — Beginning Jan. 15, private health insurers will be required to cover the cost of home testing kits despite... Read More

WASHINGTON — Beginning Jan. 15, private health insurers will be required to cover the cost of home testing kits despite recent concerns from elected officials and researchers over the reliability and availability of rapid antigen testing. “I’ve heard from so many people who are waiting in... Read More

January 12, 2022
by Alexa Hornbeck
COVID Pills Show Promise for Combating Severe Infection

Pfizer’s Paxlovid is the first pill treatment to combat severe COVID-19 infection, and new figures from Israel’s Ministry of Health... Read More

Pfizer’s Paxlovid is the first pill treatment to combat severe COVID-19 infection, and new figures from Israel’s Ministry of Health show the pill may hold promise in saving lives. Shortly before Christmas Day, Paxlovid was authorized for at-home treatment of high-risk COVID-19 infections in patients over... Read More

January 12, 2022
by Alexa Hornbeck
Researchers Develop mRNA-based Lyme Disease Vaccine

Yale researchers recently developed an mRNA-based Lyme disease vaccine capable of targeting antigens in tick saliva to prevent their ability... Read More

Yale researchers recently developed an mRNA-based Lyme disease vaccine capable of targeting antigens in tick saliva to prevent their ability to transmit pathogens.  According to the CDC, nearly half a million people in the U.S. are diagnosed with Lyme Disease every year. The ailment is most... Read More

News From The Well
Exit mobile version